18F-AV-1451 PET Imaging in TBI
NCT02512029 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2016-02-05
Summary
This study will evaluate imaging characteristics of 18F-AV-1451 in subjects with subacute traumatic brain injury.
Conditions
Interventions
- DRUG
-
18F-AV-1451
Sponsors & Collaborators
-
Avid Radiopharmaceuticals
lead INDUSTRY
Principal Investigators
-
Chief Medical Officer · Avid Radiopharmaceuticals, Inc.
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2017-04-30
- Completion
- 2017-04-30
Countries
- United States
Study Locations
More Related Trials
-
PET-MRI in Chronic Traumatic Brain Injury (CTBI)
NCT03241732 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
18F-AV-1451 Autopsy Study
NCT02516046 ·Status: COMPLETED ·Phase: PHASE3
-
Synaptic Density, Tau and Multiparametric PET-MR in Brain Trauma, Stroke and Mild Cognitive or Behavioral Impairment.
NCT03514524 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
PET Tau - Neurodegenerative Disease Imaging
NCT03143374 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
NCT06103201 ·Status: RECRUITING ·Phase: PHASE1
-
Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
NCT02795780 ·Status: COMPLETED ·Phase: PHASE2
-
PET Imaging in Chronic Traumatic Encephalopathy
NCT02211820 ·Status: COMPLETED
-
PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers
NCT01826110 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging of Traumatic Brain Injury
NCT01196299 ·Status: COMPLETED
-
Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury
NCT02266563 ·Status: COMPLETED
-
Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy
NCT03999164 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Tau PET Imaging in the NACC Study Cohort
NCT03189485 ·Status: ACTIVE_NOT_RECRUITING
-
Advanced Imaging Tools in the Study of Mild Traumatic Brain Injury
NCT01044615 ·Status: COMPLETED
-
Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
NCT05337774 ·Status: TERMINATED ·Phase: PHASE1
-
Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI
NCT01812213 ·Status: TERMINATED ·Phase: PHASE2
-
Translocator Protein and Inflammation After Traumatic Brain Injury
NCT01547780 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Rapid MRI for Assessing Functional Abilities and Predicting TBI Outcomes
NCT06454591 ·Status: RECRUITING
-
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia
NCT00613119 ·Status: COMPLETED
-
Tau PET Imaging in Atypical Dementias
NCT03283449 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Predictive Neuroinflammatory Biomarkers of Neuro-radiological Evolution in Severe Traumatic Brain Injury
NCT03659006 ·Status: UNKNOWN ·Phase: NA
-
Imaging Tau Deposition in the Brain of Elderly Subjects
NCT02958670 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
NCT01503944 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Flortaucipir PET Imaging in Subjects With FTD
NCT03040713 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
NCT01209156 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
NCT01992380 ·Status: COMPLETED ·Phase: PHASE1